openPR Logo
Press release

Investigation for Investors in shares of Bausch Health Companies Inc. (NYSE: BHC) announced over potential Wrongdoing by certain directors

09-10-2021 04:28 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Bausch Health Companies Inc. (NYSE: BHC) shares over potential wrongdoing.

An investigation on behalf of investors in Bausch Health Companies Inc. (NYSE: BHC) shares over potential wrongdoing.

Certain directors of Bausch Health Companies Inc. are under investigation over potential breaches of fiduciary duties.

Investors who purchased shares of Bausch Health Companies Inc. (NYSE: BHC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Bausch Health Companies directors breached their fiduciary duties and caused damage to the company and its shareholders.

Canada based Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. reported that its annual Total Revenue declined from $8.6 billion in 2019 to $8.027 billion in 2020, and that its Net Loss declined from over $1.78 billion in 2019 to $560 million in 2020.

On August 3, 2021, Bausch Health Companies Inc announced its financial and operating results for the second quarter of 2021. Among other results, Bausch Health Companies Inc reported a net loss of $595 million compared to $236 million for the same period in 2020, citing an unfavorable change in operating results coupled with a decrease in the benefit from income taxes. Bausch also reported an operating loss of $270 million, compared to $27 million for the same period in 2020, which the Company stated was primarily driven by the increase in Other expense, primarily attributable to higher adjustments related to the settlement of certain litigation matters in the second quarter of 2021, an increase in Selling, general and administrative expenses and the impacts of a recall due to a quality issue at a third-party supplier partially offset by an increase in contribution due to the positive impacts of the recovery of the COVID-19 pandemic.

Shares of Bausch Health Companies Inc (NYSE: BHC) declined from $34.57 per share in March 2021 to as low as $24.91 per share on August 4, 2021.

Those who purchased shares of Bausch Health Companies Inc. (NYSE: BHC) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Investors in shares of Bausch Health Companies Inc. (NYSE: BHC) announced over potential Wrongdoing by certain directors here

News-ID: 2388630 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Bausch

Ocular Implants Market 2022 Development Status - Alcon, Inc., Bausch & Lomb
Ocular Implants Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis. It
Vision Care Market Precise Outlook 2019- Johnson & Johnson, The Cooper Companies …
"Global Vision Care Market: Size, Trends & Forecasts (2019-2023 Edition)"research study is segmented on the basis of applications, technology, geography and types. The report provides a detailed Vision Care Industry Overview along with the analysis of industry's gross margin, cost structure, consumption value, and sale price. The leading companies of the Vision Care Market, manufacturers, and distributors are profiled in the report alongwith the latest Industry development current and future
Vision Care Market 2020 Precise Outlook - Johnson & Johnson, The Cooper Companie …
The Vision Care Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Vision care refers to the
Global Conjunctivitis Market 2018 – Novartis, Santen Pharmaceutical, Bausch + …
The conjunctivitis Market has dominated many regions of the world in recent years. According to the world conjunctivitis market report, it will continue to govern in the coming years. The increasing demand of the conjunctivitis market and the various business opportunities have driven the growth of conjunctivitis. The market for conjunctivitis shows a gradual increase in recent years. Specifies the market forecast of conjunctivitis from 2018 to 2022. To begin with,
Latest Development of Global Elderly and Disabled Assistive Devices Market Repor …
Researchmoz added Most up-to-date research on "Global Elderly and Disabled Assistive Devices Sales Market Report 2018" to its huge collection of research reports. This report studies the global Elderly and Disabled Assistive Devices market status and forecast, categorizes the global Elderly and Disabled Assistive Devices market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast
Artificial Tears Market Trends, Key players (Allergan, Alcon, Bausch)
A new business intelligence report released by HTF MI with title “Global Artificial Tears Market Analysis 2012-2017 and Forecast 2018-2023” that targets and provides comprehensive market analysis with future prospects to 2023. The analysts of the study have garnered extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. Request Sample Report @: